The most important advantage of our study is that this is the first study to examine the associationsofMMP-2-1306 C/T and MMP-1-1607 1G/2G polymorphisms with the risk of prostate cancer using meta-analysis. The gene discussed is MMP1; the disease is prostate carcinoma.